17
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      To submit to Bentham Journals, please click here

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Use of Saline as a Placebo in Intra-articular Injections in Osteoarthritis: Potential Contributions to Nociceptive Pain Relief

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background:

          Osteoarthritis of the knee (OAK) is a severe debilitating condition characterized by joint pain, stiffness, and resultant limited mobility. In recent years, intra-articular (IA) injections have been used to relieve symptoms and have succeeded to varying degrees either with sodium hyaluronate preparations or with a biologic.

          Objective:

          The objective of this review is to evaluate multiple studies that demonstrate some relief from the symptoms of OAK in the saline arm of various clinical trials.

          Method:

          A thorough literature search (PubMed) was performed assessing the pain efficacy of various compounds compared to saline injections in clinical trials. A total of 73 studies were identified in the literature search including a total of 5,816 patients. These clinical trials all involved the IA injection of a viscosupplement (hyaluronate, platelet rich plasma (PRP), etc.) or a biologic (the low molecular weight fraction (< 5kDa) of human serum albumin (LMWF-5A)). For all of these studies, the control arm was injection of sterile physiological saline that approximates the salt concentration and total solute concentration of blood and most tissues.

          Results:

          Based on our review of the current literature, the tested compounds performed with mixed results when compared to saline injections. Moreover, OAK is a variable disease, with severity measured on the Kellgren and Lawrence (KL) scale where various hyaluronate preparations have a therapeutic effect mostly on KL 2-3 patients while a biologic works best on KL 3-4 patients.

          Conclusion:

          Since the effect of saline injection is always greater than no treatment, the evaluations of these treatments can be confounded in clinical trials. Therefore, the question of whether there are known therapeutic effects of saline injections might explain these results.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials

          To use meta-analysis techniques to evaluate the efficacy and safety of platelet-rich plasma (PRP) injections for the treatment knee of osteoarthritis (OA).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Osteoarthritis pain: nociceptive or neuropathic?

            In this article, we present the case for the existence of a subgroup of patients with osteoarthritis (OA) who experience pain with neuropathic features. Recognizing these patients as a distinct subgroup will allow clinicians to improve the management of their symptoms. We discuss the diagnostic criteria for pain to be classed as neuropathic, then systematically examine the applicability of these criteria to the symptoms, signs and pathology of OA. What are the implications for the preclinical development and clinical use of analgesics for OA? How should existing treatment options be reassessed? Differences in the aetiology of OA and the pharmacological sensitivity of patients with OA pain with neuropathic features, compared with other patients with OA, might explain the frequent negative findings of clinical trials of treatments for symptomatic OA. If the global prevalence of OA pain with neuropathic features is accurately represented by reports from small experimental groups of patients, then a substantial unmet need to tailor diagnosis and therapy for these individuals exists.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity.

              Hypertonicity (most often present as high salinity) is stressful to the cells of virtually all organisms. Cells survive in a hypertonic environment by increasing the transcription of genes whose products catalyze cellular accumulation of compatible osmolytes. In mammals, the kidney medulla is normally hypertonic because of the urinary concentrating mechanism. Cellular accumulation of compatible osmolytes in the renal medulla is catalyzed by the sodium/myo-inositol cotransporter (SMIT), the sodium/chloride/betaine cotransporter, and aldose reductase (synthesis of sorbitol). The importance of compatible osmolytes is underscored by the necrotic injury of the renal medulla and subsequent renal failure that results from the inhibition of SMIT in vivo by administration of a specific inhibitor. Tonicity-responsive enhancers (TonE) play a key role in hypertonicity-induced transcriptional stimulation of SMIT, sodium/chloride/betaine cotransporter, and aldose reductase. We report the cDNA cloning of human TonE binding protein (TonEBP), a transcription factor that stimulates transcription through its binding to TonE sequences via a Rel-like DNA binding domain. Western blot and immunohistochemical analyses of cells cultured in hypertonic medium reveal that exposure to hypertonicity elicits slow activation of TonEBP, which is the result of an increase in TonEBP amount and translocation to the nucleus.
                Bookmark

                Author and article information

                Journal
                Open Rheumatol J
                Open Rheumatol J
                TORJ
                The Open Rheumatology Journal
                Bentham Open
                1874-3129
                31 January 2017
                2017
                : 11
                : 16-22
                Affiliations
                [1 ]Swedish Medical Center, Trauma Research, Englewood, CO 80133, USA
                [2 ]St. Anthony Hospital, Lakewood, CO 80228, USA
                [3 ]The Medical Center of Plano, Plano, TX 75075, USA
                [4 ]Penrose Hospital, Colorado Springs, CO 80907, USA
                [5 ]Ampio Pharmaceuticals Inc., Englewood, CO 80112, USA
                [6 ]SomaLogic Inc., Boulder, CO 80301, USA
                Author notes
                [* ]Address correspondence to this author at the Swedish Medical Center/Trauma Research Department, 501 E. Hampden Ave., Room 4-454, Englewood, CO 80113 USA; Tel: (303) 788-4089; Fax: (303) 788-4064; E-mail: dbaror@ 123456ampiopharma.com
                Article
                TORJ-11-16
                10.2174/1874312901711010016
                5366377
                28400868
                ad3b6196-6fab-4620-8369-1b63dbeb4c5b
                © Bar-Or et al.; Licensee Bentham Open

                This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

                History
                : 07 December 2016
                : 06 January 2017
                : 08 January 2017
                Categories
                Article

                Rheumatology
                biologicals,clinical trial,osteoarthritis,neuropathic pain,nociceptive pain,pain relief
                Rheumatology
                biologicals, clinical trial, osteoarthritis, neuropathic pain, nociceptive pain, pain relief

                Comments

                Comment on this article